Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alto Neuroscience (ANRO) Share-based Compensation (2023 - 2026)

Alto Neuroscience has reported Share-based Compensation over the past 4 years, most recently at $2.8 million for Q1 2026.

  • Quarterly results put Share-based Compensation at $2.8 million for Q1 2026, up 43.5% from a year ago — trailing twelve months through Mar 2026 was $9.0 million (up 20.81% YoY), and the annual figure for FY2025 was $8.1 million, up 6.25%.
  • Share-based Compensation reached $2.8 million in Q1 2026 per ANRO's latest filing, up from $1.9 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $2.8 million in Q1 2026 and bottomed at $484000.0 in Q1 2023.
  • Median Share-based Compensation over the past 4 years was $1.9 million (2025), compared with a mean of $1.7 million.
  • The largest annual shift saw Share-based Compensation surged 350.21% in 2024 before it dropped 9.68% in 2025.
  • Over 4 years, Share-based Compensation stood at $606000.0 in 2023, then skyrocketed by 158.42% to $1.6 million in 2024, then grew by 24.27% to $1.9 million in 2025, then skyrocketed by 45.12% to $2.8 million in 2026.
  • Business Quant data shows Share-based Compensation for ANRO at $2.8 million in Q1 2026, $1.9 million in Q4 2025, and $2.2 million in Q3 2025.